F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer​

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer​

RSS » New York Times News » NYTHealth

F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancer​

August 28, 2026

00biz-pancreatic-cancer-01-tzwf-mediumSquareAt3X-sEB7NF-rss

 In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.  

Creator: The New York Times (NYTHealth)

Source URL

Related Posts

  • Food and Water
Food Safety Culture: Protecting Health From Farm to Fork
Food Safety Culture
  • Food and Water
Hidden Hunger Crisis: Why Enough Food Isn’t Enough
Hidden Hunger Crisis
  • Public Awareness and Engagement
Healthy Childhood Environments Shape Lifelong Health
Healthy Childhood Environments

Most Recent

  • Book and Article Reviews
One Health Book Review: A Comprehensive Analysis 
One Health Book Review
  • Careers
Value of MPH in One Health: Career Benefits and Impact
Value of MPH in One Health
  • Community Stories
Malaria Control Strategies: One Health in Action
Malaria Control Community Stories

Spheres of Focus

Infectious Diseases

Climate & Disasters

Food &
Water

Natural
Resources

Built
Environments

Technology & Data

Featured Posts